[APLS] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[APLS] Apellis Pharmaceuticals, Inc.
Announcement Date
07-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -22.63%
YoY- 2.20%
Quarter Report
APLS's Result
APLS's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 94,969 44,846 22,663 22,056 16,322 14,381 60,290 35.49%
PBT -121,843 -177,496 -167,462 -190,823 -155,491 -137,727 -147,581 -12.02%
Tax 194 282 -1,471 446 486 1,208 352 -32.85%
NP -122,037 -177,778 -165,991 -191,269 -155,977 -138,935 -147,933 -12.07%
Tax Rate - - - - - - - -
Total Cost 217,006 222,624 188,654 213,325 172,299 153,316 208,223 2.80%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -128.50 -396.42 -732.43 -867.20 -955.62 -966.10 -245.37 -35.10%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -1.02 -1.56 -1.50 -1.75 -1.46 -1.42 -1.73 -29.75%
EPS Diluted -1.02 -1.56 -1.50 -1.75 -1.46 -1.42 -1.73 -29.75%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.